Live Price
Live Volume
Chart Volume 0
Volume 0
5 secAltimmune Market Segments
Premarket
+0.00(+0.00%)
| Open | $2.74 |
|---|---|
| Close | $2.74 |
| Low | $2.74 |
| Low Change | 0.00 (0.00%) |
| High | $2.74 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 200 |
| Dollar Volume | $548.00 |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.03(+1.25%)
| Open | $2.74 |
|---|---|
| Close | $2.77 |
| Low | $2.72 |
| Low Change | -0.01 (-0.53%) |
| High | $2.77 |
| High Change | +0.04 (+1.36%) |
| Range | $0.05 |
| Volume | 414.83K |
| Dollar Volume | $1.15M |
Regular Trading Hours Yesterday
-0.06(-2.14%)
| Open | $2.80 |
|---|---|
| Close | $2.74 |
| Low | $2.71 |
| Low Change | -0.09 (-3.21%) |
| High | $2.81 |
| High Change | +0.01 (+0.36%) |
| Range | $0.10 |
| Volume | 3.822M |
| Dollar Volume | $10.47M |
Premarket Yesterday
+0.03(+1.08%)
| Open | $2.77 |
|---|---|
| Close | $2.80 |
| Low | $2.76 |
| Low Change | -0.01 (-0.36%) |
| High | $2.81 |
| High Change | +0.04 (+1.50%) |
| Range | $0.05 |
| Volume | 13.774K |
| Dollar Volume | $38.57K |
Altimmune News
2 months agoinvesting.comWhy is Altimmune stock surging today?
- 2 months agoinvesting.com
Altimmune stock surges 18% on positive trial results
6 months agobenzinga.comWhy Is Altimmune Stock Falling Today?
- 8 months agoinvesting.com
Altimmune stock falls after announcing $75 million direct offering
- 9 months agoinvesting.com
ALT Technologies to be acquired by CCL Industries
- 9 months agoinvesting.com
Altimmune stock soars after FDA grants Breakthrough Therapy status
- 10 months agoinvesting.com
Altimmune stock tumbles after MASH drug trial data
Altimmune Top Trades
Altimmune's top trade so far today returned +0.00%, while the top short trade returned 0.00%.
Altimmune Moving Averages
| 5 Day Moving Average (SMA5) | $2.85 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.02 |
| 20 Day Moving Average (SMA20) | $3.16 |
| 50 Day Moving Average (SMA50) | $3.09 |
| 100 Day Moving Average (SMA100) | $2.99 |
| 200 Day Moving Average (SMA200) | $3.46 |
Altimmune Statistics
| Average Volume (30 Days) | 3.84M |
|---|---|
| P/E Ratio (Current) | -5.87 |
| EPS (Current) | -$0.47 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$76.56M |
| Cash Ratio | 5.04 |
| Current Ratio | 26.78 |
| Quick Ratio | 26.78 |
| Debt to Equity | 0.07 |
| Enterprise Value | $508.60M |
| EV to EBITDA | -5.08 |
| EV to Sales | 16406.54 |
| Price to Book | 1.13 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 17318.35 |
| Return on Assets | -0.17% |
| Return on Equity | -0.19% |
Altimmune Stock Splits
There have been 3 stock splits for Altimmune (ALT). The last reverse stock split occured on September 14, 2018 and reduced the outstanding shares at a ratio of 30:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 14, 2018 | Reverse | 30:1 |
| May 4, 2017 | Reverse | 10:1 |
| Jul 25, 2007 | Reverse | 50:1 |
Altimmune Dividends
There have been no dividends for Altimmune (ALT).